Lupin Ltd Drug Patent Portfolio

Lupin Ltd's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lupin Ltd News

Lupin Reaches $90 Million Settlement with Astellas Over Drug Patent Conflict - Bloomberg Law News

10 Feb, 2026

Sun Pharma receives approval to market generic Wegovy in India - The HinduBusinessLine

23 Jan, 2026

Indian Pharmaceutical Sector Q3: Stable Revenue, Profit Decline Due to US Generic Drugs and Increasing Expenses

21 Jan, 2026

Upcoming expirations of GLP-1 drug patents attract generic manufacturers - C&EN

09 Dec, 2025

See More